Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results Article Swipe

PDF

Nigel Bundred , Núria Porta , Adrian Murray Brunt , Angela Cramer , Andrew M. Hanby , Abeer M. Shaaban , Emad A. Rakha , Anne Armstrong , Ramsey Cutress , David Dodwell , Marie A. Emson , Abigail Evans , Sue M. Hartup , Kieran Horgan , Sarah E. Miller , Stuart McIntosh , James P. Morden , Jay Naik , Sankaran Narayanan , Jane Ooi , Anthony Skene , David Cameron , Judith M. Bliss ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.22487958

Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Related Topics

Trastuzumab

Medicine

Randomized Controlled Trial

Concepts

Lapatinib Trastuzumab Medicine Perioperative Randomized controlled trial Breast cancer Oncology Internal medicine Cancer Surgery

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.22487958
PDF: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_from_Combined_Perioperative_Lapatinib_and_Trastuzumab_in_Early_HER2-Positive_Breast_Cancer_Identifies_Early_Responders_Randomized_UK_EPHOS-B_Trial_Long-Term_Results/22487958/1/files/39939564.pdf
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4361963647

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4361963647

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.22487958

Digital Object Identifier
Title: Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-31

Full publication date if available
Authors: Nigel Bundred, Núria Porta, Adrian Murray Brunt, Angela Cramer, Andrew M. Hanby, Abeer M. Shaaban, Emad A. Rakha, Anne Armstrong, Ramsey Cutress, David Dodwell, Marie A. Emson, Abigail Evans, Sue M. Hartup, Kieran Horgan, Sarah E. Miller, Stuart McIntosh, James P. Morden, Jay Naik, Sankaran Narayanan, Jane Ooi, Anthony Skene, David Cameron, Judith M. Bliss

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.22487958

Publisher landing page
PDF URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_from_Combined_Perioperative_Lapatinib_and_Trastuzumab_in_Early_HER2-Positive_Breast_Cancer_Identifies_Early_Responders_Randomized_UK_EPHOS-B_Trial_Long-Term_Results/22487958/1/files/39939564.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_from_Combined_Perioperative_Lapatinib_and_Trastuzumab_in_Early_HER2-Positive_Breast_Cancer_Identifies_Early_Responders_Randomized_UK_EPHOS-B_Trial_Long-Term_Results/22487958/1/files/39939564.pdf

Direct OA link when available
Concepts: Lapatinib, Trastuzumab, Medicine, Perioperative, Randomized controlled trial, Breast cancer, Oncology, Internal medicine, Cancer, Surgery

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4361963647
doi	https://doi.org/10.1158/1078-0432.22487958
ids.doi	https://doi.org/10.1158/1078-0432.22487958
ids.openalex	https://openalex.org/W4361963647
fwci
type	preprint
title	Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10755
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9934999942779541
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2730
topics[0].subfield.display_name	Oncology
topics[0].display_name	HER2/EGFR in Cancer Research
topics[1].id	https://openalex.org/T10336
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9732000231742859
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	Cancer Cells and Metastasis
topics[2].id	https://openalex.org/T12829
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9708999991416931
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2740
topics[2].subfield.display_name	Pulmonary and Respiratory Medicine
topics[2].display_name	Advanced Breast Cancer Therapies
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2777329042
concepts[0].level	5
concepts[0].score	0.9557780027389526
concepts[0].wikidata	https://www.wikidata.org/wiki/Q420323
concepts[0].display_name	Lapatinib
concepts[1].id	https://openalex.org/C2779786085
concepts[1].level	4
concepts[1].score	0.9202773571014404
concepts[1].wikidata	https://www.wikidata.org/wiki/Q412616
concepts[1].display_name	Trastuzumab
concepts[2].id	https://openalex.org/C71924100
concepts[2].level	0
concepts[2].score	0.7750418186187744
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[2].display_name	Medicine
concepts[3].id	https://openalex.org/C31174226
concepts[3].level	2
concepts[3].score	0.7369861006736755
concepts[3].wikidata	https://www.wikidata.org/wiki/Q64855140
concepts[3].display_name	Perioperative
concepts[4].id	https://openalex.org/C168563851
concepts[4].level	2
concepts[4].score	0.6422619819641113
concepts[4].wikidata	https://www.wikidata.org/wiki/Q1436668
concepts[4].display_name	Randomized controlled trial
concepts[5].id	https://openalex.org/C530470458
concepts[5].level	3
concepts[5].score	0.5768115520477295
concepts[5].wikidata	https://www.wikidata.org/wiki/Q128581
concepts[5].display_name	Breast cancer
concepts[6].id	https://openalex.org/C143998085
concepts[6].level	1
concepts[6].score	0.5580148696899414
concepts[6].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[6].display_name	Oncology
concepts[7].id	https://openalex.org/C126322002
concepts[7].level	1
concepts[7].score	0.5437610745429993
concepts[7].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[7].display_name	Internal medicine
concepts[8].id	https://openalex.org/C121608353
concepts[8].level	2
concepts[8].score	0.3858453035354614
concepts[8].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[8].display_name	Cancer
concepts[9].id	https://openalex.org/C141071460
concepts[9].level	1
concepts[9].score	0.2819538116455078
concepts[9].wikidata	https://www.wikidata.org/wiki/Q40821
concepts[9].display_name	Surgery
keywords[0].id	https://openalex.org/keywords/lapatinib
keywords[0].score	0.9557780027389526
keywords[0].display_name	Lapatinib
keywords[1].id	https://openalex.org/keywords/trastuzumab
keywords[1].score	0.9202773571014404
keywords[1].display_name	Trastuzumab
keywords[2].id	https://openalex.org/keywords/medicine
keywords[2].score	0.7750418186187744
keywords[2].display_name	Medicine
keywords[3].id	https://openalex.org/keywords/perioperative
keywords[3].score	0.7369861006736755
keywords[3].display_name	Perioperative
keywords[4].id	https://openalex.org/keywords/randomized-controlled-trial
keywords[4].score	0.6422619819641113
keywords[4].display_name	Randomized controlled trial
keywords[5].id	https://openalex.org/keywords/breast-cancer
keywords[5].score	0.5768115520477295
keywords[5].display_name	Breast cancer
keywords[6].id	https://openalex.org/keywords/oncology
keywords[6].score	0.5580148696899414
keywords[6].display_name	Oncology
keywords[7].id	https://openalex.org/keywords/internal-medicine
keywords[7].score	0.5437610745429993
keywords[7].display_name	Internal medicine
keywords[8].id	https://openalex.org/keywords/cancer
keywords[8].score	0.3858453035354614
keywords[8].display_name	Cancer
keywords[9].id	https://openalex.org/keywords/surgery
keywords[9].score	0.2819538116455078
keywords[9].display_name	Surgery
language	en
locations[0].id	doi:10.1158/1078-0432.22487958
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_from_Combined_Perioperative_Lapatinib_and_Trastuzumab_in_Early_HER2-Positive_Breast_Cancer_Identifies_Early_Responders_Randomized_UK_EPHOS-B_Trial_Long-Term_Results/22487958/1/files/39939564.pdf
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.22487958
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5071040536
authorships[0].author.orcid	https://orcid.org/0000-0001-6007-056X
authorships[0].author.display_name	Nigel Bundred
authorships[0].author_position	first
authorships[0].raw_author_name	Nigel Bundred
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5074540413
authorships[1].author.orcid	https://orcid.org/0000-0003-2458-2167
authorships[1].author.display_name	Núria Porta
authorships[1].author_position	middle
authorships[1].raw_author_name	Nuria Porta
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5058248316
authorships[2].author.orcid	https://orcid.org/0000-0002-4797-5097
authorships[2].author.display_name	Adrian Murray Brunt
authorships[2].author_position	middle
authorships[2].raw_author_name	Adrian Murray Brunt
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5043626932
authorships[3].author.orcid	https://orcid.org/0009-0007-4837-3745
authorships[3].author.display_name	Angela Cramer
authorships[3].author_position	middle
authorships[3].raw_author_name	Angela Cramer
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5112814511
authorships[4].author.orcid
authorships[4].author.display_name	Andrew M. Hanby
authorships[4].author_position	middle
authorships[4].raw_author_name	Andrew Hanby
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5004074922
authorships[5].author.orcid	https://orcid.org/0000-0001-5784-8705
authorships[5].author.display_name	Abeer M. Shaaban
authorships[5].author_position	middle
authorships[5].raw_author_name	Abeer M. Shaaban
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5020838260
authorships[6].author.orcid	https://orcid.org/0000-0002-5009-5525
authorships[6].author.display_name	Emad A. Rakha
authorships[6].author_position	middle
authorships[6].raw_author_name	Emad A. Rakha
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5056491116
authorships[7].author.orcid	https://orcid.org/0000-0002-0774-7006
authorships[7].author.display_name	Anne Armstrong
authorships[7].author_position	middle
authorships[7].raw_author_name	Anne Armstrong
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5067824020
authorships[8].author.orcid	https://orcid.org/0000-0002-1719-7255
authorships[8].author.display_name	Ramsey Cutress
authorships[8].author_position	middle
authorships[8].raw_author_name	Ramsey I. Cutress
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5002979606
authorships[9].author.orcid	https://orcid.org/0000-0001-8787-4904
authorships[9].author.display_name	David Dodwell
authorships[9].author_position	middle
authorships[9].raw_author_name	David Dodwell
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5048782694
authorships[10].author.orcid
authorships[10].author.display_name	Marie A. Emson
authorships[10].author_position	middle
authorships[10].raw_author_name	Marie A. Emson
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5019381008
authorships[11].author.orcid
authorships[11].author.display_name	Abigail Evans
authorships[11].author_position	middle
authorships[11].raw_author_name	Abigail Evans
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5042234098
authorships[12].author.orcid	https://orcid.org/0000-0002-8852-7872
authorships[12].author.display_name	Sue M. Hartup
authorships[12].author_position	middle
authorships[12].raw_author_name	Sue M. Hartup
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5091627649
authorships[13].author.orcid	https://orcid.org/0000-0003-4173-1777
authorships[13].author.display_name	Kieran Horgan
authorships[13].author_position	middle
authorships[13].raw_author_name	Kieran Horgan
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5065128217
authorships[14].author.orcid	https://orcid.org/0000-0002-5192-4567
authorships[14].author.display_name	Sarah E. Miller
authorships[14].author_position	middle
authorships[14].raw_author_name	Sarah E. Miller
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5038170474
authorships[15].author.orcid	https://orcid.org/0000-0002-4123-9611
authorships[15].author.display_name	Stuart McIntosh
authorships[15].author_position	middle
authorships[15].raw_author_name	Stuart A. McIntosh
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5043736497
authorships[16].author.orcid	https://orcid.org/0000-0002-5684-2296
authorships[16].author.display_name	James P. Morden
authorships[16].author_position	middle
authorships[16].raw_author_name	James P. Morden
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5074320946
authorships[17].author.orcid	https://orcid.org/0000-0002-4793-8878
authorships[17].author.display_name	Jay Naik
authorships[17].author_position	middle
authorships[17].raw_author_name	Jay Naik
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5042950747
authorships[18].author.orcid	https://orcid.org/0000-0002-1929-5887
authorships[18].author.display_name	Sankaran Narayanan
authorships[18].author_position	middle
authorships[18].raw_author_name	Sankaran Narayanan
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5109843433
authorships[19].author.orcid
authorships[19].author.display_name	Jane Ooi
authorships[19].author_position	middle
authorships[19].raw_author_name	Jane Ooi
authorships[19].is_corresponding	False
authorships[20].author.id	https://openalex.org/A5108833439
authorships[20].author.orcid
authorships[20].author.display_name	Anthony Skene
authorships[20].author_position	middle
authorships[20].raw_author_name	Anthony I. Skene
authorships[20].is_corresponding	False
authorships[21].author.id	https://openalex.org/A5007286394
authorships[21].author.orcid	https://orcid.org/0000-0002-2717-7979
authorships[21].author.display_name	David Cameron
authorships[21].author_position	middle
authorships[21].raw_author_name	David A. Cameron
authorships[21].is_corresponding	False
authorships[22].author.id	https://openalex.org/A5006665510
authorships[22].author.orcid	https://orcid.org/0000-0001-7957-7424
authorships[22].author.display_name	Judith M. Bliss
authorships[22].author_position	last
authorships[22].raw_author_name	Judith M. Bliss
authorships[22].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_from_Combined_Perioperative_Lapatinib_and_Trastuzumab_in_Early_HER2-Positive_Breast_Cancer_Identifies_Early_Responders_Randomized_UK_EPHOS-B_Trial_Long-Term_Results/22487958/1/files/39939564.pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
has_fulltext	False
is_retracted	False
updated_date	2025-11-27T01:12:40.094763
primary_topic.id	https://openalex.org/T10755
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9934999942779541
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2730
primary_topic.subfield.display_name	Oncology
primary_topic.display_name	HER2/EGFR in Cancer Research
related_works	https://openalex.org/W2166148619, https://openalex.org/W1967506091, https://openalex.org/W2326908302, https://openalex.org/W2989981638, https://openalex.org/W2167587342, https://openalex.org/W2262572336, https://openalex.org/W67104293, https://openalex.org/W1964065629, https://openalex.org/W2530207093, https://openalex.org/W3098385676
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/1078-0432.22487958
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_from_Combined_Perioperative_Lapatinib_and_Trastuzumab_in_Early_HER2-Positive_Breast_Cancer_Identifies_Early_Responders_Randomized_UK_EPHOS-B_Trial_Long-Term_Results/22487958/1/files/39939564.pdf
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.22487958
primary_location.id	doi:10.1158/1078-0432.22487958
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_from_Combined_Perioperative_Lapatinib_and_Trastuzumab_in_Early_HER2-Positive_Breast_Cancer_Identifies_Early_Responders_Randomized_UK_EPHOS-B_Trial_Long-Term_Results/22487958/1/files/39939564.pdf
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.22487958
publication_date	2023-03-31
publication_year	2023
referenced_works_count	0
abstract_inverted_index.UK	17
abstract_inverted_index.in	8
abstract_inverted_index.and	6
abstract_inverted_index.from	2
abstract_inverted_index.Early	9, 14
abstract_inverted_index.Trial	19
abstract_inverted_index.Breast	11
abstract_inverted_index.Cancer	12
abstract_inverted_index.Figure	1
abstract_inverted_index.EPHOS-B	18
abstract_inverted_index.Results	21
abstract_inverted_index.Combined	3
abstract_inverted_index.Lapatinib	5
abstract_inverted_index.Long-Term	20
abstract_inverted_index.Identifies	13
abstract_inverted_index.Randomized	16
abstract_inverted_index.Responders:	15
abstract_inverted_index.Trastuzumab	7
abstract_inverted_index.HER2-Positive	10
abstract_inverted_index.Perioperative	4
abstract_inverted_index.Supplementary	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	23
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.4099999964237213
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.19446535
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False